Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and ΔFosB expression in the striatum and locomotor sensitization in mice

Neuroscience

Volumn 157, Issue 3, 2008, Pages 644-655

  Shen, H Y ^a   Kalda, A ^a   Yu, L ^a   Ferrara, J ^a   Zhu, J ^a   Chen, J F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amphetamine; butyric acid; cAMP responsive element binding protein; chromatin immunoprecipitation; histone deacetylase; valproic acid

Indexed keywords

AMPHETAMINE; BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE H4; SERINE; TRANSCRIPTION FACTOR FOSB; VALPROIC ACID;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG POTENTIATION; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ACETYLATION; AMPHETAMINE; ANIMALS; BUTYRIC ACID; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATIN IMMUNOPRECIPITATION; CORPUS STRIATUM; CREB-BINDING PROTEIN; DRUG INTERACTIONS; ENZYME INHIBITORS; GENE EXPRESSION; HISTONES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; TIME FACTORS; VALPROIC ACID;

EID: 56049126838     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.09.019     Document Type: Article

References (58)

1. Abel T., and Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8 (2008) 57-64
2. Barrett L.E., Sul J.Y., Takano H., Van Bockstaele E.J., Haydon P.G., and Eberwine J.H. Region-directed phototransfection reveals the functional significance of a dendritically synthesized transcription factor. Nat Methods 3 (2006) 455-460
3. Berke J.D., and Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25 (2000) 515-532
4. Brami-Cherrier K., Valjent E., Herve D., Darragh J., Corvol J.C., Pages C., Arthur S.J., Girault J.A., and Caboche J. Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci 25 (2005) 11444-11454
5. Canettieri G., Morantte I., Guzman E., Asahara H., Herzig S., Anderson S.D., Yates III J.R., and Montminy M. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat Struct Biol 10 (2003) 175-181
6. Carlezon Jr. W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
7. Chawla S., Vanhoutte P., Arnold F.J., Huang C.L., and Bading H. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85 (2003) 151-159
8. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., and Nestler E.J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci 17 (1997) 4933-4941
9. Colvis C.M., Pollock J.D., Goodman R.H., Impey S., Dunn J., Mandel G., Champagne F.A., Mayford M., Korzus E., Kumar A., Renthal W., Theobald D.E., and Nestler E.J. Epigenetic mechanisms and gene networks in the nervous system. J Neurosci 25 (2005) 10379-10389
10. Crosio C., Heitz E., Allis C.D., Borrelli E., and Sassone-Corsi P. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 116 (2003) 4905-4914
11. Della Ragione F., Criniti V., Della Pietra V., Borriello A., Oliva A., Indaco S., Yamamoto T., and Zappia V. Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett 499 (2001) 199-204
12. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23 (2003) 7311-7316
13. Farooq M., Sulochana K.N., Pan X., To J., Sheng D., Gong Z., and Ge R. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev Biol 317 (2008) 336-353
14. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., and Hersch S.M. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23 (2003) 9418-9427
15. Fiol C.J., Williams J.S., Chou C.H., Wang Q.M., Roach P.J., and Andrisani O.M. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem 269 (1994) 32187-32193
16. Guan Z., Giustetto M., Lomvardas S., Kim J.H., Miniaci M.C., Schwartz J.H., Thanos D., and Kandel E.R. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111 (2002) 483-493
17. Gui C.Y., and Dean A. Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2. Mol Cell Biol 21 (2001) 1155-1163
18. Gui C.Y., Ngo L., Xu W.S., Richon V.M., and Marks P.A. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci U S A 101 (2004) 1241-1246
19. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci 24 (2004) 6590-6599
20. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., and Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13 (1994) 1235-1244
21. Jeong M.R., Hashimoto R., Senatorov V.V., Fujimaki K., Ren M., Lee M.S., and Chuang D.M. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 542 (2003) 74-78
22. Johnson K.D., and Bresnick E.H. Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods 26 (2002) 27-36
23. Kalda A., Heidmets L.T., Shen H.Y., Zharkovsky A., and Chen J.F. Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice. Behav Brain Res 181 (2007) 76-84
24. Konkel D.A., Maizel Jr. J.V., and Leder P. The evolution and sequence comparison of two recently diverged mouse chromosomal beta-globin genes. Cell 18 (1979) 865-873
25. Konradi C., Cole R.L., Heckers S., and Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14 (1994) 5623-5634
26. Korzus E., Rosenfeld M.G., and Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42 (2004) 961-972
27. Kumar A., Choi K.H., Renthal W., Tsankova N.M., Theobald D.E., Truong H.T., Russo S.J., Laplant Q., Sasaki T.S., Whistler K.N., Neve R.L., Self D.W., and Nestler E.J. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48 (2005) 303-314
28. Leng Y., Liang M.H., Ren M., Marinova Z., Leeds P., and Chuang D.M. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. J Neurosci 28 (2008) 2576-2588
29. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., and Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279 (2004) 40545-40559
30. Levine A.A., Guan Z., Barco A., Xu S., Kandel E.R., and Schwartz J.H. CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci U S A 102 (2005) 19186-19191
31. Li J., Guo Y., Schroeder F.A., Youngs R.M., Schmidt T.W., Ferris C., Konradi C., and Akbarian S. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 90 (2004) 1117-1131
32. Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58 (1999) 31-59
33. Maldonado R., Blendy J.A., Tzavara E., Gass P., Roques B.P., Hanoune J., and Schutz G. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273 (1996) 657-659
34. Mattson M.P. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2 (2003) 329-342
35. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 6 (2003) 1208-1215
36. Michael L.F., Asahara H., Shulman A.I., Kraus W.L., and Montminy M. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol Cell Biol 20 (2000) 1596-1603
37. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
38. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
39. Nestler E.J., Barrot M., and Self D.W. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A 98 (2001) 11042-11046
40. Ren M., Leng Y., Jeong M., Leeds P.R., and Chuang D.M. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89 (2004) 1358-1367
41. Renz M., Neuberg M., Kurz C., Bravo R., and Muller R. Regulation of c-fos transcription in mouse fibroblasts: identification of DNase I-hypersensitive sites and regulatory upstream sequences. EMBO J 4 (1985) 3711-3716
42. Roth S.Y., Denu J.M., and Allis C.D. Histone acetyltransferases. Annu Rev Biochem 70 (2001) 81-120
43. Ryu H., Lee J., Olofsson B.A., Mwidau A., Dedeoglu A., Escudero M., Flemington E., Azizkhan-Clifford J., Ferrante R.J., and Ratan R.R. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A 100 (2003) 4281-4286
44. Sassone-Corsi P. The decline of induced transcription: a case of enzymatic symbiosis. Nat Struct Biol 10 (2003) 151-152
45. Shen H.Y., He J.C., Wang Y., Huang Q.Y., and Chen J.F. Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice. J Biol Chem 280 (2005) 39962-39969
46. Tenbrock K., Juang Y.T., Leukert N., Roth J., and Tsokos G.C. The transcriptional repressor cAMP response element modulator alpha interacts with histone deacetylase 1 to repress promoter activity. J Immunol 177 (2006) 6159-6164
47. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., and Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 99 (2002) 17095-17100
48. Tsankova N.M., Kumar A., and Nestler E.J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24 (2004) 5603-5610
49. Turgeon S.M., Pollack A.E., and Fink J.S. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res 749 (1997) 120-126
50. Turgeon S.M., Pollack A.E., Schusheim L., and Fink J.S. Effects of selective adenosine A1 and A2a agonists on amphetamine- induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res 707 (1996) 75-80
51. Ulery P.G., Rudenko G., and Nestler E.J. Regulation of DeltaFosB stability by phosphorylation. J Neurosci 26 (2006) 5131-5142
52. Valverde O., Mantamadiotis T., Torrecilla M., Ugedo L., Pineda J., Bleckmann S., Gass P., Kretz O., Mitchell J.M., Schutz G., and Maldonado R. Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 29 (2004) 1122-1133
53. Van Lint C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5 (1996) 245-253
54. Weaver I.C., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., and Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25 (2005) 11045-11054
55. Weaver I.C., D'Alessio A.C., Brown S.E., Hellstrom I.C., Dymov S., Sharma S., Szyf M., and Meaney M.J. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci 27 (2007) 1756-1768
56. Wells J., and Farnham P.J. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26 (2002) 48-56
57. Yasuda S., Liang M.H., Marinova Z., Yahyavi A., and Chuang D.M. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry (2007) Oct 9; [Epub ahead of print] doi: 10.1038/sj.mp.4002099
58. Yildirim E., Zhang Z., Uz T., Chen C.Q., Manev R., and Manev H. Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci Lett 345 (2003) 141-143